KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Inventory (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Inventory for 16 consecutive years, with $30.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 3.94% to $30.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.2 million, a 3.94% increase, with the full-year FY2025 number at $30.2 million, up 3.94% from a year prior.
  • Inventory was $30.2 million for Q4 2025 at Biolife Solutions, up from $27.8 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $43.4 million in Q1 2024 to a low of $11.7 million in Q1 2021.
  • A 5-year average of $31.5 million and a median of $30.2 million in 2022 define the central range for Inventory.
  • Peak YoY movement for Inventory: soared 169.06% in 2021, then tumbled 36.5% in 2025.
  • Biolife Solutions' Inventory stood at $28.3 million in 2021, then grew by 23.14% to $34.9 million in 2022, then decreased by 22.18% to $27.2 million in 2023, then grew by 6.81% to $29.0 million in 2024, then increased by 3.94% to $30.2 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Inventory are $30.2 million (Q4 2025), $27.8 million (Q3 2025), and $27.7 million (Q2 2025).